‘Mini-lungs’ reveal early stages of S... - Lung Conditions C...

Lung Conditions Community Forum

56,327 members66,958 posts

‘Mini-lungs’ reveal early stages of SARS-CoV-2 infection

2greys profile image
7 Replies

‘Mini-lungs’ grown from tissue donated to Cambridge hospitals has provided a team of scientists from South Korea and the UK with important insights into how COVID-19 damages the lungs. Writing in the journal Cell Stem Cell, the researchers detail the mechanisms underlying SARS-CoV-2 infection and the early innate immune response in the lungs.

To date, there have been more than 40 million cases of COVID-19 and almost 1.13 million deaths worldwide. The main target tissues of SARS-CoV-2, the virus that causes COVID-19, especially in patients that develop pneumonia, appear to be alveoli – tiny air sacs in the lungs that take up the oxygen we breathe and exchange it with carbon dioxide to exhale.

To better understand how SARS-CoV-2 infects the lungs and causes disease, a team of scientists from the UK and South Korea turned to organoids – ‘mini-organs’ grown in three dimensions to mimic the behaviour of tissue and organs.

bioengineer.org/mini-lungs-...

Cell Stem Cell. Research (PDF file):

reader.elsevier.com/reader/...

Written by
2greys profile image
2greys
To view profiles and participate in discussions please or .
Read more about...
7 Replies
SquirrelsHolt profile image
SquirrelsHolt

Evening all 👮‍♀️! Excellent piece of reading there 2greys . Thank

you for passing it on to us. 🐿🌈

cesces profile image
cesces

It would appear they learned nothing of substance.

2greys profile image
2greys in reply tocesces

“Based on our model we can tackle many unanswered key questions, such as understanding genetic susceptibility to SARS-CoV-2, assessing relative infectivity of viral mutants, and revealing the damage processes of the virus in human alveolar cells,” said Dr Young Seok Ju, co-senior author, and an Associate Professor at Korea Advanced Institute of Science and Technology. “Most importantly, it provides the opportunity to develop and screen potential therapeutic agents against SARS-CoV-2 infection.”

Daisy55 profile image
Daisy55

How interesting , thank you x

Alberta56 profile image
Alberta56

Sounds promising

Izb1 profile image
Izb1

Amazing what they can do, we just dont know what is going on behind the scenes x

Dilly2 profile image
Dilly2

Interesting thanks 2greys.

Not what you're looking for?

You may also like...

Immunological memory after SARS-CoV-2 infection recovery. *The welcome news we have been waiting for*

Until now, it was unclear whether a survived SARS-CoV-2 infection or COVID-19 leads to a persistent...
2greys profile image

Singapore scientists uncover SARS-CoV-2-specific T cell immunity.

A Singapore study has uncovered the presence of virus-specific T cell immunity in people who...
2greys profile image

Discovery of a druggable pocket in the SARS-CoV-2 Spike protein could stop virus in its tracks.

A druggable pocket in the SARS-CoV-2 Spike protein that could be used to stop the virus from...
2greys profile image

Pfizer BioNTech vaccine likely to be effective against B1.1.7 strain of SARS-CoV-2.

The preliminary data, which have yet to be to peer-reviewed and relate to only a small number of...
2greys profile image

Could SARS-CoV-2 evolve resistance to COVID-19 vaccines?

Similar to bacteria evolving resistance to antibiotics, viruses can evolve resistance to vaccines,...
2greys profile image